(Arylamidoaryl)squaramide compounds
    8.
    发明申请
    (Arylamidoaryl)squaramide compounds 失效
    (芳酰氨基芳基)方酰胺化合物

    公开(公告)号:US20060111349A1

    公开(公告)日:2006-05-25

    申请号:US11227699

    申请日:2005-09-15

    CPC分类号: C07D409/14 C07D409/12

    摘要: Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R5, m and J are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.

    摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐或N-氧化物,其中A,Q,Y,R 5,m和J如本文所定义,可用于治疗肿瘤 和肥大细胞增多症/肥大细胞白血病,胃肠道间质肿瘤(GIST),生殖细胞肿瘤,小细胞肺癌(SCLC),鼻窦自然杀伤/ T细胞淋巴瘤,睾丸癌(精原细胞瘤),甲状腺癌,恶性黑素瘤, 卵巢癌,腺样囊性癌,急性骨髓性白血病(AML),乳腺癌,儿科T细胞急性淋巴细胞白血病,成神经细胞瘤,肥大细胞白血病,血管肉瘤,间变性大细胞淋巴瘤,子宫内膜癌和前列腺癌。